 |
Health Care Services and Financing Grants
Grants listed by date, with most recent appearing first. Click a grant title for detailed information, including a summary and publications.
| Barriers to the Adoption of Pharmacotherapies in Publicly Funded Substance Abuse Treatment: Policy Barriers and Access to Physicians, Hannah Knudsen, Ph.D. |
| Assessing State Adoption of Medicaid HCPCS Billing Codes for Screening & Brief Intervention of Substance Use, Holly Fussell, Ph.D. |
| The Adoption of Pharmaceutical Technologies in Addiction Treatment, Carolyn Heinrich, Ph.D. |
| Medicaid and Public Funding for Buprenorphine Treatment of Opioid Dependence, David Fiellin, M.D. |
| Staff Quality in Methadone Treatment Programs, Tzy-Mey Kuo, M.P.H., Ph.D. |
| Reducing or Expanding Substance Use Disorder Treatment Programs: Evaluating Impact from the Health Care Decision-Maker's Perspective, Keith Humphreys, Ph.D. |
| Service Delivery and Use of Evidence-Based Treatment Practice in Adolescent Substance Abuse Treatment Settings, Lori Ducharme, Ph.D. |
| Drug Treatment and Mental Health Services: Ethnic Differences in Access and Outcomes, Noosha Niv, Ph.D. |
| Drug Treatment and Mental Health Services: Access and Outcomes, Yih-Ing Hser, Ph.D. |
| Improving Treatment for Medicaid Beneficiaries with Co-occurring Disorders, Vince S. Thomas, Ph.D. |
| Understanding the Impacts of Funding Volatility on Treatment Services, Patricia Ebener, |
| Effects of Reductions in Oregon Health Plan Coverage of Substance Abuse and Mental Health Services on Its Most Vulnerable Citizens, Roy Gabriel, Ph.D. |
| Race/Ethnicity Disparities in the Availability of Support and Ancillary Services in Opioid Treatment Programs, Nancy Berkman, Ph.D. |
| RAND Cross-Site Evaluation of a National Demonstration Project for State Systems Improvement for Care of Individuals with Co-Occurring Substance Related and Mental Disorders, Harold Pincus, M.D. |
| A National Survey of Physicians' Adolescent Drug Testing Practices, Sharon Levy, M.D., M.P.H. |
| Policy Implications of Different Treatment Approaches for Individuals with Co-Occurring Substance Abuse and Mental Health Disorders, Constance Weisner, Dr.P.H., M.S.W. |
| Mental Health and Substance Abuse in Publicly Funded Treatment Systems, Bentson McFarland, M.D., Ph.D. |
| Substance Abuse and Indian Child Welfare, Paul Spicer, Ph.D. |
| Cost Analysis and Operations Assessment of Community-based Alcohol and Drug Treatment Program, Yih-Ing Hser, Ph.D. |
| Drug Crackdowns and Illicit Drug Injectors' Health, Hannah Cooper, Sc.D. |
| Translating Alcohol Intervention Research into Clinical Trauma Centers, Carol Schermer, M.D., M.P.H. |
| A Study of Online Counseling and Internet Use Among Family Drug Court Participants, Susanna Nemes, Ph.D. |
| Public Financing and Treatment for Dual Disorders: A Case Study, Robin Clark, Ph.D. |
| A Policy Analysis of Changes in Federal Methadone Treatment Regulation, Deborah Podus, Ph.D. |
| Reimbursement Policy for Online Substance Abuse Treatment, Farrokh Alemi, Ph.D. |
| Substance Abuse Treatment for Pregnant Women Under Managed Care, Janet Mitchell, Ph.D. |
| Costs and Benefits of Prison-Based Treatment Plus Aftercare Drug-Abusing Offenders, Kathryn McCollister, Ph.D. |
| A Follow-up Study of Medicaid Chemical Dependency Patients in a Private HMO: Do High Medical Costs Come Down over Time?, Lawrence Walter, M.A. |
| Impact of Managed Care Contracting Arrangements on Access to Substance Abuse Services, Janet Mitchell, Ph.D. |
| Supplement to: Elimination of Drug and Alcohol Abuse as an Eligibility Category for SSI, Shanthi Kappagoda, M.S. |
| The Impact of Welfare Reform on Mothers Convicted of a Drug Offense, Carol Boyd, M.S.N., Ph.D., R.N. |
| Pathways to Substance Abuse Treatment for Adolescents in an HMO: Implications for Policy, Constance Weisner, Dr.P.H., M.S.W. |
| Welfare Reform and Substance Abuse Policy Changes: Reducing the Harm to Parents, Heroin Addicts, and Disabled Persons, Richard Speiglman, D.Crim. |
| The Sensitivity of Drug Abuse Treatment Demand to Copayment Levels, Anthony Lo Sasso, Ph.D. |
| Identifying Best Practices among Managed Care Plans that Provide Substance Abuse Treatment Services to Medicaid Recipients with Disabilities, Sara Bachman, Ph.D. |
| Integrated versus Referred Out Methadone Treatment: Quality and Costs, Daniel Polsky, Ph.D. |
| Cost Effectiveness of Prenatal/postnatal Treatment/interventions for Drug Abusing Pregnant Women, Jean Bailey, Ph.D. |
| Comparison of Utilization and Costs of Medicaid and non-Medicaid Chemical Dependency Patients in a Group Model HMO, Lawrence Walter, M.A. |
| "Parity" for Substance Abuse Benefits under Managed Care, Roland Sturm, Ph.D. |
| Substance Abuse and Welfare Reform, Sheldon Danziger, Ph.D. |
| Moving Substance Users from Welfare to Work in the State of Florida: The Impact of Welfare Reform and Drug Treatment, Lisa Metsch, Ph.D. |
| Mortality Follow-Up of Trauma Patients, Patricia Dischinger, Ph.D. |
| Developing a Foundation for Outcome Based Purchasing of Addictions Treatment, Norman Hoffmann, Ph.D. |
| Public Hospital Systems and Managed Care for Drug Involved Mothers and their Children, Dennis Andrulis, Ph.D., MPH |
| The Social Impact of Withdrawal of SSI Benefits for Drug and Alcohol Addiction, James Kahn, M.D., M.P.H. |
| Effects of the Elimination of SSI Drug Addiction and Alcoholism Eligibility: Phase 2, Richard Speiglman, D.Crim. |
| State Policies and Practices Addressing the Substance Abuse, Medicaid, and Employment Needs of Recipients of Welfare, Diane Woolis, Ed.D.
Ed.D. |
| Impact of Terminating DA&A SSI/SSDI Benefits, Paul Goldstein, Ph.D. |
| Determinants of Public Support for Drug Treatment: 1972-1996, Kenneth Rasinski, Ph.D. |
| Refining of a Model to Assess Smoking-related Medical
Care Expenditures, Vince Miller, Ph.D. |
| Effects of the Elimination of SSI Drug Addiction and Alcoholism: Phase I, Richard Speiglman, D.Crim. |
| Illicit Drug Control: Criminal Justice vs. Public Health, Henry Saffer, Ph.D. |
| Analysis of the Cost Effectiveness of Correctional Substance Abuse Treatment Programs, Craig Love, Ph.D. |
|
|
